2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections (Q40705383)
Jump to navigation
Jump to search
scientific article published on September 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections |
scientific article published on September 2002 |
Statements
1 reference
2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections (English)
1 reference
Anne Bousseau
1 reference
Christine Roy
1 reference
Laurence Lagneaux
1 reference
Susan Michelson
1 reference
Dominique Bron
1 reference
Michael J Otto
1 reference
Conception Nemecek
1 reference
1 September 2002
1 reference
1 reference
Identifiers
1 reference